Tumor-infiltrating lymphocytes (TILs) are a robust prognostic adjunct in invasive breast cancer, but their clinical role in ductal carcinoma in situ (DCIS) has not been ascertained.
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast / G. Pruneri, M. Lazzeroni, V. Bagnardi, G.B. Tiburzio, N. Rotmensz, A. Decensi, A. Guerrieri-Gonzaga, A. Vingiani, G. Curigliano, S. Zurrida, F. Bassi, R. Salgado, G. Van den Eynden, S. Loi, C. Denkert, B. Bonanni, G. Viale. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 28:2(2017 Feb 01), pp. 321-328. [10.1093/annonc/mdw623]
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast
G. Pruneri;A. Vingiani;G. Curigliano;S. Zurrida;G. VialeUltimo
2017
Abstract
Tumor-infiltrating lymphocytes (TILs) are a robust prognostic adjunct in invasive breast cancer, but their clinical role in ductal carcinoma in situ (DCIS) has not been ascertained.
| File | Dimensione | Formato | |
|---|---|---|---|
|
TILs in DCIS_annals.pdf
accesso riservato
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
385.11 kB
Formato
Adobe PDF
|
385.11 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
